Prnewswire·2025-09-23 21:30Core Insights - Class Action Attorney Juan Monteverde and his firm, Monteverde & Associates PC, are investigating Metsera, Inc. regarding its proposed sale to Pfizer Inc. [1] - The transaction offers Metsera shareholders $47.50 per share in cash at closing, along with a contingent value right that could provide up to an additional $22.50 per share based on specific clinical and regulatory milestones [1] Company Overview - Monteverde & Associates PC is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report and has a successful track record in recovering funds for shareholders [1] - The firm operates from the Empire State Building in New York City and has experience in trial and appellate courts, including the U.S. Supreme Court [2] Transaction Details - The proposed deal with Pfizer includes a cash payment of $47.50 per share and potential additional payments of up to $22.50 per share, contingent on achieving three specific milestones [1]